These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6814550)

  • 21. Assembly and GPIIIa content of cytoskeletal core in platelets agglutinated with bovine von Willebrand factor.
    Puszkin EG; Mauss EA; Zucker MB
    Blood; 1990 Oct; 76(8):1572-9. PubMed ID: 2119831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelets, von Willebrand factor, and prostaglandin I2.
    Moake JL; Tang SS; Olson JD; Troll JH; Cimo PL; Davies PJ
    Am J Physiol; 1981 Jul; 241(1):H54-9. PubMed ID: 6787937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Borate and glycerol inhibition of the aggregation of guinea pig platelets by bovine factor VIII and ristocetin.
    Kuwahara SS
    Am J Hematol; 1977; 2(2):159-72. PubMed ID: 888824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Res; 1999 Sep; 95(6):315-23. PubMed ID: 10527409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
    Zucker MB; Puszkin EG; Sussman II; Mauss EA
    J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
    Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
    Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of human blood platelets with the 2',3'-dialdehyde and 2',3'-dialcohol derivatives of adenosine 5'-diphosphate and adenosine 5'-triphosphate.
    Pearce PH; Wright JM; Egan CM; Scrutton MC
    Eur J Biochem; 1978 Aug; 88(2):543-54. PubMed ID: 689037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of ADP secretion and thromboxane synthesis in factor VIII binding to platelets.
    Di Minno G; Shapiro SS; Catalano PM; De Marco L; Murphy S
    Blood; 1983 Jul; 62(1):186-90. PubMed ID: 6407547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Observations on the effects of cytochalasin B and cytochalasin D on ADP- and chymotrypsin-treated platelets.
    Peerschke EI
    Proc Soc Exp Biol Med; 1984 Jan; 175(1):109-15. PubMed ID: 6694966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposure.
    Figures WR; Niewiarowski S; Morinelli TA; Colman RF; Colman RW
    J Biol Chem; 1981 Aug; 256(15):7789-95. PubMed ID: 6267026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ["In vitro" effect of factor VIII concentrates on human normal platelets (author's transl)].
    Grignani G; Ortis M; Gamba G; Ascari E
    Haematologica; 1978 Apr; 63(2):132-42. PubMed ID: 98398
    [No Abstract]   [Full Text] [Related]  

  • 32. Factor VIII and human platelet aggregation. II. Characteristics of aggregation of human platelets by bovine factor VIII.
    Bottecchia D; Vermylen J
    Br J Haematol; 1976 Oct; 34(2):313-20. PubMed ID: 987797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
    Oliver JA; Albrecht RM
    Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet aggregation: its relation with ADP-induced fibrinogen binding to platelets and ADP-related membrane enzyme activities.
    Legrand C; Dubernard V; Caen J
    Eur J Biochem; 1984 Aug; 142(3):465-71. PubMed ID: 6088225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
    Huzoor-Akbar ; Anwer K
    Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM; Limbird LE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous platelet aggregation in a hereditary giant platelet syndrome (MPS).
    Milton JG; Frojmovic MM; Tang SS; White JG
    Am J Pathol; 1984 Feb; 114(2):336-45. PubMed ID: 6696046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of sodium periodate on platelet functions.
    Cazenave JP; Reimers HJ; Kinlough-Rathbone RL; Packham MA; Mustard JF
    Lab Invest; 1976 May; 34(5):471-81. PubMed ID: 178961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane.
    DiMinno G; Silver MJ; Cerbone AM; Riccardi G; Rivellese A; Mancini M; Thiagarajan P
    Blood; 1985 Jan; 65(1):156-62. PubMed ID: 2981130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of human platelets separated from blood by ADP-induced aggregation.
    Mohammad SF; Reddick RL; Mason RG
    Am J Pathol; 1975 Apr; 79(1):81-94. PubMed ID: 1124800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.